Piclidenoson
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Piclidenoson, covering 2022-04-22 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome [Phase 2]